A Real-World Descriptive Study of Renal Outcomes Among Patients with ANCA-Associated Vasculitis Initiating Remission Induction Therapy

被引：0
|
作者：
Oh, Sam [1 ]
Inguva, Sushmitha [2 ]
Rane, Pallavi [2 ]
Tumminello, Brian [3 ]
机构：
[1] Amgen Inc, San Francisco, CA USA
[2] Amgen Inc, Thousand Oaks, CA USA
[3] Amgen Inc, San Juan Capistrano, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2379
引用
收藏
页码：4715 / 4717
页数：3
相关论文
共 50 条
  • [1] Outcomes of remission induction therapy for ANCA-associated vasculitis in the elderly
    Faten Aqeel
    Lillian Xu
    Antonio Salas
    Yumeng Wen
    Shaker M. Eid
    Duvuru Geetha
    Clinical Rheumatology, 2023, 42 : 2427 - 2435
  • [2] Outcomes of remission induction therapy for ANCA-associated vasculitis in the elderly
    Aqeel, Faten
    Xu, Lillian
    Salas, Antonio
    Wen, Yumeng
    Eid, Shaker M.
    Geetha, Duvuru
    CLINICAL RHEUMATOLOGY, 2023, 42 (09) : 2427 - 2435
  • [3] Advances in remission induction therapy for ANCA-associated vasculitis
    Morris, Adam
    Geetha, Duvuru
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2023, 37 (01):
  • [4] Remission induction in ANCA-associated vasculitis
    Hellmich, B.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (02): : 194 - 195
  • [5] A STEROID-SPARING REGIMEN FOR REMISSION INDUCTION THERAPY IN RENAL ANCA-ASSOCIATED VASCULITIS
    McAdoo, Stephen Paul
    Bedi, Rachna
    Galliford, Jack
    Griffith, Megan
    Cairns, Thomas
    Pusey, Charles
    RHEUMATOLOGY, 2017, 56 : 156 - 156
  • [6] Rituximab for remission induction in elderly patients with ANCA-associated vasculitis
    Timlin, H.
    Lee, S. M.
    Manno, R. L.
    Seo, P.
    Geetha, Duvura
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 45 (01) : 67 - 69
  • [7] DESIGN OF AVACOSTAR: A REAL-WORLD STUDY OF AVACOPAN IN ANCA-ASSOCIATED VASCULITIS (AAV)
    Jayne, D. R. W.
    Luqmani, R.
    Terrier, B.
    Obergfell, A.
    Pollet, C.
    Balcells, M.
    Boff, M.
    Hellmich, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [8] Baseline Characteristics of the First Patients in AvacoStar, a Real-World Study of Avacopan in ANCA-Associated Vasculitis
    Obergfell, Achim
    Jayne, David R. W.
    Luqmani, Raashid Ahmed
    Terrier, Benjamin
    Flint, Shaun
    Boff, Marie Elise
    Balcells-Oliver, Monica
    Hellmich, Bernhard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [9] DETERMINANTS OF RITUXIMAB PHARMACOKINETICS AND REMISSION INDUCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Cornec, Divi
    Kabat, Brian F.
    Mills, John R.
    Cheu, Melissa
    Hummel, Amber M.
    Schroeder, Darrell R.
    Cascino, Matthew D.
    Brunetta, Paul
    Murray, David L.
    Snyder, Melissa R.
    Fervenza, Fernando
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Langford, Carol A.
    Merkel, Peter A.
    Monach, Paul A.
    Seo, Philip
    Spiera, Robert F.
    Clair, E. William St.
    Stone, John H.
    Barnidge, David R.
    Specks, Ulrich
    RHEUMATOLOGY, 2017, 56 : 154 - 154
  • [10] CLINICAL PROFILE AND ECONOMIC BURDEN OF ANCA-ASSOCIATED VASCULITIS: A REAL-WORLD STUDY AMONG THE ITALIAN POPULATION
    Perrone, V
    Veronesi, C.
    Dovizio, M.
    Alessandrini, D.
    Ancona, D. D.
    Cillo, M. R.
    De Francesco, A.
    Dell'Orco, S.
    Ferrante, F.
    Lombardi, R.
    Pastorello, M.
    Rizzi, F., V
    Ubertazzo, L.
    Vercellone, A.
    Serna, Ramirez de Arellano A.
    Degli Esposti, L.
    VALUE IN HEALTH, 2022, 25 (01) : S64 - S65
12345